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abstract
 
We previously found that native cyclic nucleotide–gated (CNG) cation channels from amphibian rod
cells are directly and reversibly inhibited by analogues of diacylglycerol (DAG), but little is known about the mech-
anism of this inhibition. We recently determined that, at saturating cGMP concentrations, DAG completely inhib-
its cloned bovine rod (Brod) CNG channels while only partially inhibiting cloned rat olfactory (Rolf) channels
 
(Crary, J.I., D.M. Dean, W. Nguitragool, P.T. Kurshan, and A.L. Zimmerman. 2000. 
 
J. Gen. Phys
 
. 116:755–768; in
this issue). Here, we report that a point mutation at position 204 in the S2–S3 loop of Rolf and a mouse CNG
channel (Molf) found in olfactory epithelium and heart, increased DAG sensitivity to that of the Brod channel.
Mutation of this residue from the wild-type glycine to a glutamate (Molf G204E) or aspartate (Molf G204D) gave
dramatic increases in DAG sensitivity without changing the apparent cGMP or cAMP afﬁnities or efﬁcacies. How-
ever, unlike the wild-type olfactory channels, these mutants demonstrated voltage-dependent gating with obvious
activation and deactivation kinetics. Interestingly, the mutants were also more sensitive to inhibition by the local
anesthetic, tetracaine. Replacement of the position 204 glycine with a tryptophan residue (Rolf G204W) not only
gave voltage-dependent gating and an increased sensitivity to DAG and tetracaine, but also showed reduced appar-
ent agonist afﬁnity and cAMP efﬁcacy. Sequence comparisons show that the glycine at position 204 in the S2–S3
loop is highly conserved, and our ﬁndings indicate that its alteration can have critical consequences for channel
gating and inhibition.
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INTRODUCTION
 
Cyclic nucleotide–gated (CNG)
 
1
 
 cation channels are
best characterized in the visual and olfactory systems,
but they are also present in tissues as diverse as the
heart (Biel et al., 1993; Ruiz et al., 1996), brain (King-
ston et al., 1996; Bradley et al., 1997), and kidney (Biel
et al., 1994; Karlson et al., 1995). These channels (for
reviews see Kaupp, 1995; Molday and Hsu, 1995; Yau
and Chen, 1995; Zimmerman, 1995; Finn et al., 1996;
Zagotta and Siegelbaum, 1996; Wei et al., 1998; Broillet
and Firestein, 1999) are activated by carboxyl-terminal
binding of cGMP or cAMP, and most are nonselective
cation channels that regulate the membrane potential
 
and Ca
 
2
 
1
 
 inﬂux. Other cellular factors modulate the
apparent afﬁnity of the channels for cyclic nucleotides
and may be involved in regulating physiological re-
sponses. These modulators include the following: phos-
phorylation enzymes (Gordon et al., 1992; Molokanova
et al., 1997; Muller et al., 1998), calcium/calmodulin
(Hsu and Molday, 1993; Chen and Yau, 1994; Gordon
et al., 1995b); and lipids, including diacylglycerol
(DAG; Gordon et al., 1995a; Womack et al., 2000).
 
The I
 
h
 
 channel in the sinoatrial node of the heart con-
trols the pacemaking activity of the heart and is regu-
lated by the binding of cAMP (DiFrancesco and Tortora,
1991). Another CNG channel, found to be diffusely
spread throughout the mouse heart, is identical to the
mouse olfactory (Molf) CNG channel, but its function
in the heart remains unknown (Ruiz et al., 1996). As
sensors of cyclic nucleotide concentrations and conduits
 
for Ca
 
2
 
1
 
 entry, these CNG channels may also play a role
in regulating the heart rate and contraction.
 
We had previously shown that DAG reversibly inhibits
the native rod channel without a phosphorylation reac-
tion as if by direct interaction with some site on the
channel (Gordon et al., 1995a). In the companion paper
(Crary et al., 2000, in this issue), we discovered that the
DAG sensitivities of the Brod and Rolf cloned channels
are quite different. In addition, using chimeras of these
two channels, we found that the transmembrane seg-
ments S2–S6 and their connecting loops seem to be im-
plicated in the differential responses to the inhibitor. In
comparison, the amino and carboxyl termini were less
critical determinants of the different responses to DAG.
Several studies have highlighted key regions that in-
ﬂuence channel gating. These include the amino and
carboxyl termini, which have been proposed to interact
during gating, as well as the C-linker, which is located
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between the last transmembrane segment and the cy-
clic nucleotide binding domain and may function as a
sensor of the binding event that triggers the allosteric
opening transition of the channel (Zong et al., 1998;
Paoletti et al., 1999)
 
. 
 
Other regions thought to be in-
volved in gating are the pore region (Bucossi et al.,
1996) and the latter portion of the amino terminus
through the S2–S3 loop (Goulding et al., 1994). Using
chimeras of Brod and Rolf CNG channels, Gordon and
Zagotta (1995) found that control of the apparent
cGMP afﬁnity was distributed diffusely throughout the
channel protein. All of this information has yet to be as-
sembled into a uniﬁed picture of channel gating.
While exploring the mechanism of inhibition by the
local anesthetic, tetracaine, Fodor et al. (1997) used a
series of Brod and Rolf chimeras to demonstrate an in-
verse relationship between the K
 
1/2
 
 for activation by
cGMP and the IC
 
50
 
 for inhibition by tetracaine. This
ﬁnding predicts that channels that are very sensitive to
tetracaine should have relatively low apparent afﬁnities
for cyclic nucleotides, and is consistent with their gen-
eral conclusion that tetracaine stabilizes the closed
state of the channel. However, we have found that Molf
G204E, Rolf G204E, and Rolf G204D, when compared
with wild-type olfactory channels, show a marked in-
crease in inhibition by tetracaine, as well as by DAG,
without a signiﬁcant change in K
 
1/2
 
 values for activation
by cGMP. However, we did detect changes in voltage de-
pendence and gating kinetics, suggesting that muta-
tions at position 204 do affect gating, and that these pa-
rameters are more sensitive indicators of channel gat-
ing than are equilibrium parameters such as K
 
1/2
 
.
These results are supported by ﬁndings with a mutant
containing a tryptophan at position 204 (Rolf G204W).
Interestingly, this mutant channel is not only very sensi-
tive to DAG and tetracaine, but it also shows voltage de-
pendence and pronounced gating kinetics, as well as
lower apparent agonist afﬁnity and cAMP efﬁcacy.
 
MATERIALS AND METHODS
 
Mutagenesis and Expression of Channels by Xenopus Oocytes
 
The plasmids containing the 
 
a
 
 subunits of Brod (CNG1) and
Rolf (CNG2) cDNA were generous gifts from W.N. Zagotta (Uni-
versity of Washington, Seattle, WA) and the mouse olfactory
(Molf G204E) clone was provided by M.L. Ruiz (Entelos, Inc.,
Menlo Park, CA) (Ruiz et al., 1996). For alternative terminology
of the channels, see Richards and Gordon (2000). All vectors and
procedures for oocyte preparation and cRNA transcription are
described in the companion article (Crary et al., 2000, in this is-
sue).
The primary sequences of the Molf G204E and Rolf clones
were aligned for comparison to identify residue differences, and
through mutagenesis and functional analysis, we conﬁrmed that
the residue at position 204 was responsible for the differential in-
hibition by DAG reported in this study. Point mutations were in-
corporated using either the Transformer™ site-directed mu-
tagenesis kit from CLONTECH Laboratories, Inc. or the Quick-
Change™ site-directed mutagenesis kit from Stratagene. Both
 
kits allow mutagenesis in our high expression vector without sub-
cloning. The mutagenic primers were designed to encode the de-
sired mutation and its surrounding sequence in which we also in-
corporated a restriction enzyme site (for initial screening pur-
poses) without altering the primary sequence of the protein. For
the conversion of the Molf G204E to wild-type Molf, the restric-
tion enzyme site that had been introduced during cloning (SacI)
was removed to convert the glutamate residue at position 204 to
glycine, which was reported in the genomic sequence (Ruiz et al.,
1996). Aside from position 204, the Molf clone sequence differed
from the Rolf sequence by 11 amino acids. To eliminate these dif-
ferences from the study, the glycine residue at position 204 in the
Rolf channel was replaced with glutamate (E), aspartate (D),
tryptophan (W), and lysine (K). However, Rolf G204K did not
give functional expression in our studies. All mutant constructs
were subjected to DNA sequencing to conﬁrm the desired se-
quences.
 
Electrophysiological Methods
 
All experiments were performed on inside-out membrane
patches excised from 
 
Xenopus
 
 oocytes that were expressing 
 
a
 
 ho-
momultimers of one of the wild-type or mutant channel types.
The cell chamber in which patches were excised consisted of a
petri dish containing 15 ml of solution with or without saturating
concentrations of cGMP. The solution compositions and method
of application are as described in the companion article (Crary
et al., 2000, in this issue).
Patch-clamp electrodes were prepared from borosilicate glass
capillaries with openings that ranged from 0.5 to 20 
 
m
 
m in diam-
eter, producing resistances of 0.6–15 M
 
V
 
. Patches were typically
excised in low divalent sodium solutions containing saturating
concentrations of cGMP (2 mM for Brod channels and 100 
 
m
 
M
for Molf and Rolf channels). A low divalent sodium solution with-
out cGMP was applied as a control to measure the resulting leak
current which was subtracted from experimental measurements
to obtain the cyclic nucleotide–activated current. We monitored
the patch for 
 
z
 
10–40 min, until patch responses to low agonist
concentrations stabilized, to ensure that any spontaneous
changes in channel behavior, such as those caused by dephos-
phorylation (Gordon et al., 1992; Molokanova et al., 1997), had
occurred before the addition of DAG to the bathing solution.
Therefore, none of these changes would be confused with the ef-
fects of DAG. Once responses to low cGMP became consistent,
we typically measured the patch current produced in response to
ranges of cGMP and/or cAMP concentrations to produce dose–
response curves before adding DAG.
Patch-clamp data acquisition and analysis were as described in
the companion article (Crary et al., 2000, in this issue). For the
analysis of the gating kinetics, the only patches excluded from
the study as uninterpretable were those in which: (a) the cur-
rents were distorted by large ion depletion effects (Zimmerman
et al., 1988); (b) the currents were very small and, therefore,
were not easily resolvable over noise; and (c) control (i.e., leak)
currents were not stable and/or linear throughout the course of
the experiment.
 
RESULTS
 
Residue at Position 204 Dictates the Response of Olfactory 
Channels to DAG
 
Sequence comparison of the Molf and Rolf clones
showed differences at 12 positions throughout the pro-
tein, and there were an extra ﬁve amino acids located at
the carboxyl-terminal tail of the Molf clone. Analysis of
the Molf channel cDNA sequence reported in the En- 
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trez database (National Center for Biotechnology Infor-
mation) revealed that 2 of the 12 changes were intro-
duced with restriction enzyme sites during cloning. The
ﬁrst of these two was a methionine changed to a valine
at position 2, and the second was a glycine changed to
glutamate at position 204. The other 10 differences ap-
pear to be true discrepancies between the Molf and Rolf
CNG channels. As will be described in more detail later,
the original Molf clone (referred to as Molf G204E) was
much more sensitive to DAG than was the wild-type Rolf
channel. A concurrent study used chimeras of the Brod
and Rolf CNG channels to locate the regions of the
Brod channel that could convey the higher sensitivity to
DAG; the transmembrane segments and their connect-
ing loops were identiﬁed as sensitive regions in the
Brod channel (Crary et al., 2000, in this issue). These
results led us to investigate the nonconservative substi-
tution at position 204, which is located in the S2–S3
loop (Fig. 1) of the Molf clone.
Site-directed mutagenesis was used to substitute the
glutamate residue at this position with the wild-type gly-
cine residue. This construct will be herein referred to as
Molf, the true wild-type channel. To eliminate potential
effects of the 11 other differences, the glycine at posi-
tion 204 in the Rolf channel was replaced with a
glutamate residue, permitting evaluation of the effect of
this isolated point mutation on the DAG sensitivity of
the Rolf channel. The requirement of a negative charge
in conveying the observed functional changes was tested
 
by substituting another negatively charged residue (as-
partate [D]), or a bulky hydrophobic residue (tryp-
tophan [W]). Residue 204 was also replaced by the posi-
tively charged residue lysine (K), but we never observed
functional expression with this construct. Fig. 1 shows
the sequence alignment of 11 homologous CNG chan-
nels in the region equivalent to residues 195–218 of the
Rolf channel. Notably, the glycine at position 204 is con-
served throughout these sequences, including in the
Brod channel, which is only 55% identical to the Rolf
channel, and must have other differences that cause its
relatively high sensitivity to DAG.
 
Apparent Agonist Afﬁnities and cAMP Efﬁcacies of Molf 
G204E and Rolf G204E CNG Channels Are Similar to those 
of Wild-type Molf and Rolf Channels
 
Dose–response curves for activation by cGMP and cAMP
in Fig. 2 demonstrate relative apparent agonist afﬁnities
for Brod, Molf, Rolf, Molf G204E, and Rolf G204E CNG
homomultimeric (
 
a
 
 only) channels. The cGMP dose–
response curve for Brod channels is shifted to the right
with respect to all other channels shown, indicating its
lower apparent afﬁnity for cGMP (Fig. 2 A). Wild-type
and mutant (G204E) rat and mouse olfactory channels
respond with similar relative apparent afﬁnities for
cGMP and cAMP (Fig. 2, A and B). Furthermore, satu-
rating concentrations of both cAMP and cGMP, which
act as full agonists, elicit maximal responses from all ol-
factory channels shown. In contrast, the Brod CNG
Figure 1. Amino acid se-
quences of the S2–S3 loop of
various wild-type CNG chan-
nels. Top diagram demon-
strates the primary structure
and membrane topology of a
CNG channel. All wild-type
sequences contain a glycine
residue at the site equivalent
to position 204 (highlighted
in bold and underlined) in
the Rolf channel. Residues
corresponding to the equiva-
lent Rolf residues at positions
199–207 are very highly con-
served in all channels. In con-
trast, there is more variation
in the carboxyl-terminal half
of the loop sequence. Rolf,
rat olfactory; Folf, ﬁsh olfac-
tory; Bolf, bovine olfactory;
Molf, mouse olfactory; Brod,
bovine rod; Hrod, human
rod; Bcone, bovine cone;
Hcone, human cone; Ccone,
chick cone; Btestis, bovine
testis; and Drosant, Drosophila
antenna. The original Molf
clone contained a mutation at position 204 (Molf G204E), and we mutated the glutamate (E) to the wild-type glycine (G). For the Rolf
channel, the glycine at 204 was replaced with either glutamate, aspartate (D), or tryptophan (W). Replacement with a lysine residue (K)
gave no functional expression. 
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channel responds with a dramatically higher apparent
afﬁnity for cGMP than for cAMP, which acts as only a
partial agonist of the channel, activating only a fraction
(5%) of the current produced by saturating levels of
cGMP, even at maximal cAMP concentrations. There-
fore, the sequence differences, including the mutation
at residue 204, between the Molf G204E and Rolf chan-
nels do not signiﬁcantly affect the apparent agonist af-
ﬁnities or efﬁcacies of the channels. For the Rolf G204D
mutant, the responses to cGMP and cAMP are similar to
that of Rolf G204E (data not shown).
 
Brod, Molf G204E, and Rolf G204E Channels Display 
Higher Sensitivity to DAG than do the Wild-type Molf and 
Rolf Channels
 
Application of DAG to the intracellular surfaces of ex-
cised patches suppressed current activated by cGMP in
all CNG channels studied in the absence of ATP, which
indicates that the inhibition does not depend on phos-
phorylation by PKC. The extent of inhibition by DAG
varied according to the concentration of agonist and
the channel type. Fig. 3 demonstrates that the addition
of DAG produced a greater inhibition of Brod and
Molf G204E channels than of Rolf CNG channels. The
current traces were recorded for each channel type at
saturating cGMP levels in both the presence and ab-
sence of DAG. The addition of 1.5 
 
m
 
M DAG had a large
effect on both the Brod and Molf G204E channels, de-
creasing the maximal current by 
 
.
 
80% in each case.
However, this dose of DAG had a small effect on the
Rolf channel, reducing its maximal current by only
14%. As seen with the native rod CNG channel (Gor-
don et al., 1995a), the suppression of current by DAG
was reversible (data not shown) when the bath was di-
luted by the addition of large volumes of solution con-
taining saturating cGMP without DAG.
To further investigate the differences observed in Fig.
3, we measured DAG dose–response curves for each
channel type at saturating concentrations of cGMP. Fig.
4 illustrates that cGMP-activated currents in Brod, Molf
G204E, and Rolf G204E channels are fully suppressed
by 
 
z
 
3 
 
m
 
M DAG, whereas the cGMP-activated currents
of the wild-type Molf and Rolf channels are much less
sensitive to the inhibitor, displaying only partial inhibi-
tion at 12 
 
m
 
M DAG. Thus, the DAG dose–response rela-
tions of Molf G204E and Rolf G204E channels closely
resemble those of Brod CNG channels (Fig. 4), even
though their apparent afﬁnities for cGMP and cAMP, as
well as their cAMP efﬁcacies (Fig. 2), resemble those of
the wild-type olfactory channels (summarized in Table
I). As discussed later, other gating properties (voltage
dependence and kinetics) of these mutant channels
were more clearly different from those of the wild-type
Figure 2. Sensitivities to cGMP and cAMP of Molf G204E and
Rolf G204E CNG channels were similar to those of the wild-type
Molf and Rolf channels. Brod and Rolf data are from the compan-
ion article (Crary et al., 2000, in this issue). Steady state, cGMP-
activated currents were measured at 1100 mV. (A) cGMP dose–
response curves for the three wild-type channels, Molf G204E, and
Rolf G204E channels. SDs are indicated by error bars. Smooth
curves were drawn by ﬁtting the averaged data with the Hill equa-
tion, I/Imax 5 [cNMP]n/(K1/2
n 1 [cNMP]n), where I is the cGMP-
or cAMP-activated current, Imax is the cGMP-activated current ob-
tained at saturating cGMP, K1/2 is the concentration of cGMP or
cAMP giving half-maximal activation, and n is the Hill coefﬁcient.
In ﬁtting the data, this relation was scaled to match the measured
maximal I/Imax (e.g., the maximal I/Imax for the rod channel in the
presence of saturating cAMP was only 0.05 [B], rather than 1, as
for saturating cGMP). The Hill relation was used only for an em-
pirical description of the data to quantify changes in the apparent
afﬁnity and maximal activation (or inhibition; see Figs. 4 and 8); it
is not meant to suggest a mechanism of channel activation or inhi-
bition by DAG. The calculated K1/2 values were 31 mM (Brod; 11
patches), 1.2 mM (Molf; 10 patches), 2.1 mM (Rolf; 18 patches),
1.9 mM (Molf G204E; 8 patches), and 1.8 mM (Rolf G204E; 6
patches). Hill ﬁts for Brod and Rolf channels are designated by
dashed lines for emphasis. (A) Dose–response curves for activation
by cAMP; the symbols are the same as those used in A. Averaged
data points are shown with the SD as error bars: Brod (8 patches),
Rolf (7 patches), Molf (5 patches), Rolf G204E (1 patch), and
Molf G204E (4 patches). Hill ﬁts to channel data indicate K1/2 val-
ues for activation by cAMP of 1.83 mM for Brod and 37 mM for
Rolf and are represented by dashed lines. See Table I for addi-
tional information. 
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olfactory channels. As expected, the behavior of the
Rolf G204D mutant was found to resemble that of Rolf
G204E (data not shown).
 
The Mutant (G204E) Olfactory Channels Show
Voltage-dependent Gating Not Observed with Wild-type 
Olfactory Channels
 
Since the Molf and Molf G204E channels had very dif-
ferent responses to DAG, it was surprising that our ini-
tial measurements of gating by cyclic nucleotides
seemed so similar. On closer inspection, we found that,
unlike wild-type olfactory channels, the Molf G204E
and Rolf G204E channels exhibited prominent voltage-
dependent gating kinetics similar to those previously
described for the native rod CNG channel (Karpen et
al., 1988). The channels are slightly voltage-dependent,
with depolarization favoring channel opening. Thus, at
positive potentials, the current increases as more chan-
nels open, and at negative potentials, the current de-
creases as channels close. In this study, we speciﬁcally
looked for similar voltage-dependent gating kinetics.
The Brod channel typically shows gating kinetics simi-
lar to those in the left panel of Fig. 5. Here, at low
[cGMP], a slow rise in the outward current occurs dur-
ing the time course of positive voltage pulses (activa-
tion kinetics), and a slow fall in current occurs during
negative voltage pulses (deactivation kinetics). Fig. 5
shows that the Molf channel (middle) has no obvious
gating kinetics, whereas Molf G204E (right) has gating
kinetics resembling those of the Brod channel (left).
The absence of detectable gating kinetics observed for
the Molf channel was also observed for the Rolf chan-
nel (data not shown). The slight rectiﬁcation seen in
the Molf current family was the same magnitude at all
cGMP concentrations, and probably reﬂects some pro-
ton block at pH 7.2 (Root and MacKinnon, 1994;
Gavazzo et al., 1997).
We also looked for evidence of voltage-dependent
gating by plotting dose–response curves for cGMP at
both 
 
1
 
100 and 
 
2
 
100 mV. Results from multiple
patches are shown in Fig. 6 for Brod, Rolf, and Rolf
G204E. To control for patch-to-patch variability in the
apparent cGMP afﬁnity, all data for each patch were
normalized to the K
 
1/2
 
 at 
 
1
 
100 mV for that patch. For
Brod and Rolf G204E, the shift in the data at 
 
2
 
100 mV
relative to 
 
1
 
100 mV indicates voltage-dependent gat-
ing. In contrast, the dose–response curves for the Rolf
channel did not shift, suggesting that gating of this
channel is not voltage-dependent. The ratios of K
 
1/2
 
 at
Figure 3. Current families from patches at saturating cGMP
showed greater inhibition of current by DAG in Molf G204E and
Brod channels than in Rolf channels. Current traces were ob-
tained from excised, inside-out patches. Leak currents in the ab-
sence of cGMP have been subtracted. Membrane potentials were
held at 0 mV and jumped in increments of 50 mV from 2100 to
1100 mV. The families on the left were obtained at saturating
cGMP (2 mM cGMP for Brod and 100 mM for Rolf and Molf
G204E), and the families on the right were obtained after the ad-
dition of 1.5 mM DAG.
Figure 4. DAG completely suppressed saturating cGMP-acti-
vated currents of Molf G204E and Rolf G204E CNG channels, but
only partially inhibited the corresponding wild-type channels at
saturating agonist concentrations. Brod and Rolf data from the
companion article (Crary et al., 2000, in this issue) are shown for
comparison. Saturating cGMP concentrations were 2 mM for Brod
channels and 100 mM for all Molf and Rolf channels. Averaged
data obtained at saturating cGMP were ﬁt with the Hill equation,
IN/INmax 5 [DAG]n/(IC50
n 1 [DAG]n) where IN is the percent in-
hibition, INmax is maximal inhibition, IC50 is the concentration of
DAG required to achieve half-maximal inhibition, and n is the Hill
coefﬁcient. As for Fig. 2, the relation was scaled to reﬂect the mea-
sured maximal IN/INmax. For the Brod, Molf G204E, and Rolf
G204E channels, the maximum inhibition was 100%. For Brod (11
patches), IC50 5 0.83 mM, and n 5 1.7; for Molf G204E (12 patches),
IC50 5 0.99 mM, and n 5 3.6; and for Rolf G204E (5 patches), IC50 5
0.73 mM and n 5 2.8. For the wild-type olfactory channels, inhibi-
tion is only partial. For Rolf (13 patches), INmax 5 31%, IC50 5
3.24 mM (denoting 15.5% inhibition), and n 5 1.4; and for Molf
(5 patches), INmax 5 17%, IC50 5 3.50 mM (denoting 8.5% inhibi-
tion), and n 5 0.8. Hill ﬁts of Brod and Rolf channels are desig-
nated by dashed lines. Error bars indicate SDs. 
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2
 
100 mV to K
 
1/2
 
 at 
 
1
 
100 mV are 1.4 and 1.7 for the
Brod and Rolf G204E channels, respectively.
 
The Rolf G204W Mutant Demonstrates Decreased Apparent 
Agonist Afﬁnities and cAMP Efﬁcacy as well as
Voltage-Dependent Gating and Higher Sensitivity to DAG
 
The families of currents in Fig. 7 A reveal observable
gating kinetics for the Rolf G204W mutant channel
that resemble those seen with the Brod channel but not
with the wild-type Rolf channel (Fig. 5). In addition,
Fig. 7 (B and C, and Table I) shows that the apparent
 
agonist afﬁnities (K
 
1/2
 
 values for cGMP and cAMP) of
Rolf G204W are intermediate between those for the
Rolf and Brod channels (Fig. 2 and Table I). Similarly,
the cAMP efﬁcacy for Rolf G204W lies between that for
the Rolf and Brod channels. The points in Fig. 7 B pro-
vide cGMP dose–response data at two different voltages
(
 
1
 
100 and 
 
2
 
100 mV), illustrating the voltage depen-
dence of gating that was observed for the Brod channel
but not for the Rolf channel (Fig. 6). Fig. 8 A and Table
I indicate that DAG inhibition of the Rolf G204W mu-
tant is even more like that of the Brod channel than are
the agonist afﬁnities and efﬁcacies; in fact, the Rolf
G204W channel is actually more sensitive to DAG than
is the Brod channel. These data show that the introduc-
tion of a bulky hydrophobic residue (tryptophan) at
position 204 in the Rolf channel has an even greater
impact on channel function than the introduction of
negatively charged residues. In Fig. 8 B, the current–
voltage relation for the Rolf G204W channel again
shows the slight voltage dependence of the mutant that
is intrinsic to gating. As observed for the Brod and Rolf
channels (Crary et. al, 2000, in this issue), the addition
of DAG does not introduce any further voltage depen-
dence than that which is expected at lower open proba-
bility (Karpen et al., 1988).
 
Residue 204 Mutants Are Also More Sensitive to Block
by Tetracaine
To explore the mechanism by which residue 204 alters
DAG sensitivity, we also studied the very different inhib-
itor, tetracaine. Tetracaine dose–response curves (data
not shown), obtained for some of the mutant channels
at saturating cGMP concentrations, indicated that the
sensitivity to tetracaine (like that to DAG) is much
greater for Molf G204E and Rolf G204D (IC50 5 10.8
mM for both mutants) than for the Rolf channel (IC50 5
139.6 mM). Thus, the response to tetracaine for both
mutants was more like that reported for the Brod chan-
TABLE I
Summary of Effects of Agonists and Inhibitors on Different
Channel Types*
cGMP cAMP DAG Tetracaine
Channel K1/2 K1/2 Efficacy‡ IC50
Maximal percent
inhibition§ IC50
i
Percent
inhibition¶
Brod 31.0 1830 0.05 0.83 100 2.6 94.1
Rolf 2.1 37 1 3.24 31 139.6 10.4
Molf 1.2 37 1 3.50 17 – 18.8
Molf G204E 1.9 37 1 0.99 100 10.8 78.3
Rolf G204E 1.8 37 1 0.73 100 – 76.4
Rolf G204W 14.0 440 0.44 0.26 100 2.2 100
*The values for K1/2 and IC50 were all obtained from Hill ﬁts of averaged
data at 1100 mV and are expressed in micromolar. All IC50 values were
obtained with saturating cGMP. Except for tetracaine IC50 values (see be-
low), the number of patches used to obtain each value is indicated in the
ﬁgure legends. For the cAMP K1/2 values, the same curve was used to ﬁt
data for Rolf, Molf, Molf G204E, and Rolf G204E (Fig. 2 B). ‡The frac-
tional current obtained with saturating cAMP relative to that obtained
with saturating cGMP. This value was obtained from the Hill ﬁts that were
used to calculate the K1/2 for averaged data, except in the case of Rolf
G204W, where the efﬁcacy was the average of values obtained at saturating
cAMP for two patches. §Maximal percent inhibition at saturating DAG
concentrations. This value was obtained from the Hill ﬁts that were used
to calculate the IC50. iThe tetracaine IC50 value reported here for Brod
was obtained from the literature (Fodor et al., 1997). The tetracaine IC50
values for Rolf, Molf G204E, and Rolf G204W were obtained from two,
one, and one patch(es), respectively.¶Percent inhibition at 40 mM.
Figure 5. A glutamate at position 204 of the Molf or Rolf channel produced gating kinetics similar to those of the Brod channel. In the
absence of DAG, the Molf channel has no detectable gating kinetics, whereas Molf G204E has obvious gating kinetics, much like the Brod
channel. Currents were obtained with either 10 mM (Brod), 1 mM (Molf), or 1 mM (Molf G204E) cGMP in response to voltage jumps rang-
ing from 2100 to 1100 mV in steps of 50 mV, from a holding potential of 0 mV. For clarity, only currents at 2100, 0, and 1100 mV are
shown. At 1100 mV, the observed currents had an I/Imax of 0.20, 0.15, and 0.15, respectively (from left to right).775 Crary et al.
nel (IC50 5 2.6 mM; Fodor et al., 1997) than that of the
Rolf channel. Fig. 9 and Table I summarize the re-
sponses of all channel types to tetracaine at saturating
cGMP concentrations (2 mM cGMP for all channels).
The percent inhibition by 40 mM tetracaine was four- to
eightfold greater for the three mutants than for their
wild-type counterparts. As found for DAG inhibition,
Rolf G204W behaved similarly to the Brod channel
with respect to tetracaine inhibition: it was 100% inhib-
ited (without deviation) at 40 mM tetracaine.
DISCUSSION
We have identiﬁed a residue in the S2–S3 loop that is
highly conserved among the CNG channel family mem-
bers, and that inﬂuences channel gating and inhibition
by DAG and tetracaine. Replacement of the glycine at
position 204 of the mouse or rat olfactory channel with
a negatively charged residue (glutamate or aspartate)
created channels with dramatically increased sensitivity
to both DAG and tetracaine but a less obvious change
in channel gating. These mutations introduced voltage
dependence and gating kinetics without a change in
apparent agonist afﬁnity or efﬁcacy. However, substitu-
tion of residue 204 with tryptophan resulted in more
dramatic effects on gating as well as higher sensitivity to
the two inhibitors. In fact, unlike the other mutants,
the tryptophan mutant demonstrated a decrease in ap-
parent agonist afﬁnity and cAMP efﬁcacy, in addition to
the appearance of voltage-dependent gating. These re-
sults indicate that it is not merely the charge of the
glutamate and aspartate residues that altered channel
gating and inhibitor sensitivities; instead, the mutations
may have changed the secondary structure or simply
the ﬂexibility of the loop region by introducing bulkier
groups than the wild-type glycine. Alternatively, the re-
placement of glycine at position 204 may have changed
the nature of interactions of this loop with other parts
of the channel. The Hill coefﬁcients from the DAG
dose–response curves of the more sensitive channels
conﬁrm that at least two or three molecules of DAG are
typically required to inhibit a channel (discussed in
more detail in the companion article Crary et al., 2000,
in this issue). This is in contrast to inhibition by tetra-
caine in which one molecule appears to block the
closed pore of the channel (Fodor et al., 1997). Consis-
tent with our results with the rod and olfactory chan-
nels (see Crary et al., 2000, in this issue), inhibition of
the mutant channels by DAG does not appear to be
voltage-dependent, but, as expected, the voltage de-
pendence of gating becomes more evident upon stabili-
zation of the closed state(s) by DAG.
The Molf G204E, Rolf G204E, and Rolf G204D con-
structs provide the ﬁrst demonstration of a point muta-
tion that drastically alters inhibition by DAG or tetra-
caine without altering the apparent sensitivity to cyclic
nucleotides. How could a change in the residue at posi-
tion 204 have a similar dramatic effect on inhibition by
two structurally different inhibitors without changing
these gating parameters? Our results suggest that gating
Figure 6. A glutamate at position 204 of the Molf or Rolf chan-
nel produced voltage-dependent gating similar to that of the Brod
channel. To analyze the data from multiple patches, the dose–
response curve from each patch was ﬁt with the Hill relation, and
each set of data was normalized to the cGMP K1/2 at 1100 mV for
that patch. Each different symbol represents the normalized data
points from a single patch; open symbols for 2100 mV and closed
symbols for 1100 mV. All points for each voltage were re-ﬁt with
the Hill equation, setting the normalized K1/2 for 1100 mV at 1.0; a
change in the normalized K1/2 at 2100 mV indicates voltage-depend-
ent gating. (A) Brod channel (six patches): at 1100 mV, n 5 2.0;
and at 2100 mV, the normalized cGMP K1/2 5 1.4 and n 5 2.0.
(B) Rolf channel (six patches): at 1100 mV, n 5 2.8; and at 2100
mV, the normalized cGMP K1/2 5 1.0 and n 5 2.8. (C) Rolf G204E
channel (2 patches): at 1100 mV, n 5 1.7; and at 2100 mV, the
normalized cGMP K1/2 5 1.7 and n 5 1.7.776 Point Mutation Alters Gating and Inhibition
kinetics are more sensitive to changes in the allosteric
conformational change than are standard equilibrium
gating parameters such as apparent cGMP afﬁnity and
cAMP efﬁcacy. Thus, unlike the wild-type olfactory chan-
nel, the aspartate and glutamate mutants demonstrated
voltage-dependent gating kinetics, resembling those
previously documented for the native rod CNG channel
(Karpen et al., 1988). We have not seen similar gating ki-
netics with the wild-type olfactory channels, but we have
seen them with the cloned rod channel as well as with
the position 204 mutants (glutamate and aspartate).
The voltage dependence was further investigated by
plotting the dose–response curves at 1100 and 2100
mV. As expected, a shift between these dose–response
curves was observed for the Brod and Rolf G204E chan-
nels, but not for the Rolf channel. These studies, dem-
onstrating weakly voltage-dependent gating, are consis-
tent with previous ﬁndings for Brod a homomultimers
(Benndorf et al., 1999) as well as those for the native
CNG channel (Karpen et al., 1988). However, one
study reported voltage dependence in the Brod hetero-
multimers (a and b subunits), but not in the Brod a
homomultimeric channels (Shammat and Gordon,
1999). The lack of voltage dependence in the Rolf a
homomultimers is consistent with the studies by Brad-
ley et al. (1994) and Liman and Buck (1994).
Although the introduction of a negative charge at po-
sition 204 produced only subtle changes in gating
properties, the substitution of a bulky hydrophobic
group (tryptophan) had more severe consequences. In-
terestingly, this single point mutation converted the ol-
factory channel to one that behaves more like the rod
channel, displaying lower apparent agonist afﬁnity,
cAMP efﬁcacy, as well as more pronounced gating ki-
netics and voltage dependence. In light of the drasti-
cally altered gating properties of the Rolf G204W mu-
tant, it is not surprising that its response to inhibitors is
also like that of the rod channel. One possible explana-
Figure 7. Introduction of tryptophan at posi-
tion 204 produced a mutant Rolf channel with
measurable gating kinetics, lower apparent ago-
nist afﬁnity, and decreased cAMP efﬁcacy. (A)
The current families were obtained with the des-
ignated amounts of cGMP in response to voltage
jumps ranging from 2100 to 1100 mV in 50-mV
steps, from a holding potential of 0 mV. The
traces were corrected for leak by subtracting re-
sponses in the absence of cGMP. (B) The dose–
response curves for activation by cGMP at 1 100
mV and 2100 mV are shown for a single patch
containing the Rolf G204W mutant; the data were
ﬁt with the Hill relation, as in Fig. 2 (see legend).
For this patch, at 1100 mV, the cGMP K1/2 5 14
mM and n 5 2.0; and at 2100 mV, the cGMP K1/2 5
18 mM and n 5 2.0. For averaged data from six
patches, at 1100 mV, the K1/2 5 14 mM and n 5
1.7; and at 2100 mV, the K1/2 5 19 mM and n 5
1.7. The Hill ﬁts (Fig. 2) for the cGMP dose–
response curves of the Rolf and Brod channels (at
1100 mV) are shown for comparison. (C) cAMP
is only a partial agonist for Rolf G204W, unlike
the Rolf channel (Hill ﬁt from Fig. 2 is shown for
comparison). A dose–response curve for activa-
tion by cAMP is shown for a single patch: K1/2 5
440 mM and n 5 0.9. The average efﬁcacy for two
patches was 44%.777 Crary et al.
tion for the larger effect of the tryptophan molecule on
channel gating is that its hydrophobic side chain may
insert into the bilayer and disrupt the normal motions
of the transmembrane segments that occur during al-
losteric transitions, in much the same way as we have
proposed for the DAG molecule (see ﬁrst model of Fig.
10 in companion article, Crary et al., 2000, in this is-
sue). Alternatively, the tryptophan may produce larger
effects on gating than glutamate or aspartate simply be-
cause it has a different effect on the secondary struc-
ture of the region.
Since glycine is present at the equivalent of position
204 in both the rod and olfactory channels (Fig. 1),
other residue differences between the two channels
must be responsible for the differential DAG inhibition
of these two channels. In fact, a parallel study with chi-
meras of the two channels demonstrated that regions
outside of the S2–S3 loop of the rod channel can also
convey DAG sensitivity (see companion article Crary et
al., 2000, in this issue). Thus, there is no clear evidence
as to whether this loop constitutes a DAG binding site;
instead, it may play a critical role in gating, such that
structural alterations may result in functional modiﬁca-
tions that also render the channel more sensitive to
closed state inhibitors. Chimera studies previously have
shown that swapping S2 and the adjoining S2–S3 loop
of bovine rod and catﬁsh olfactory channels had only
moderate effects on ligand sensitivity or efﬁcacy (Goul-
ding et al., 1994); yet, this loop is part of a larger re-
gion, including the latter part of the amino terminus,
that has been found to affect gating when the entire re-
gion is swapped. Swapping the amino-terminal part
alone gave only moderate effects. Therefore, it is possi-
ble that a nonconservative residue difference in the S2–
S3 loop of the rod channel may also contribute to the
differences in gating and sensitivity to inhibitors of the
two different channels. Further studies are required to
elucidate the role of the loop in the mechanism(s) of
channel gating and DAG inhibition.
In the lac permease of Escherichia coli, deletions in the
loops were generally not disruptive to the protein’s
function unless they encroached on the boundaries
with the transmembrane segments, where critical resi-
dues were proposed to actually be part of the trans-
membrane helix (Wolin and Kaback, 1999). Thus, in
the case of Rolf G204W, it is somewhat surprising that a
point mutation in the putative middle of the S2–S3
loop of the Rolf CNG channel alters channel behavior
so dramatically. Interestingly, mutation of a histidine
residue in the same loop of the KAT1 channel recently
has been shown to affect activation kinetics and pH de-
pendence (Tang et al., 2000). It is possible that the
wild-type S2–S3 loop has a very distinct interaction with
another part of the CNG channel, and is, therefore, di-
rectly involved in the normal allosteric transition(s)
that occur during channel gating. Alternatively, the
loop may simply be a hinge that maintains a particular
distance between (or alignment of) the transmem-
brane segments that compose the core of the channel.
A similar purpose has been proposed for the loops
in ligand-gated ion channel receptors (Lynch et al.,
1997). The structure of such a hinge may determine its
ﬂexibility, which may be critical during the conforma-
tional changes that constitute channel gating, a process
that most likely requires movement of the transmem-
brane segments in the membrane as proposed for
Figure 8. The Rolf G204W mutant had a slightly greater DAG
sensitivity than that of the Brod channel, and its inhibition was
similarly voltage-independent (compare with Fig. 4 in companion
article, Crary et al., 2000, in this issue). (A) The DAG dose–
response curve was measured in the presence of 2 mM cGMP: data
were averaged from three patches and ﬁt with the Hill equation.
The maximum inhibition for the Rolf G204W mutant was 100%
with an IC50 5 0.26 mM and n 5 3.2. The Hill ﬁts for the Brod and
Rolf channels (from Fig. 4) are shown for comparison as dashed
curves. (B) Steady state current–voltage relations obtained from
data acquired on a single patch containing the Rolf G204W mu-
tant. Open circles represent cGMP-activated currents at saturating
concentrations in the absence of DAG. Filled circles represent cur-
rents at saturating cGMP in the presence of 0.8 mM DAG. For com-
parison, the triangles show the currents at lower (5 mM) cGMP
concentration, without DAG.778 Point Mutation Alters Gating and Inhibition
other channels (Unwin, 1995; Perozo et al., 1999). Evi-
dence from work on homologous K1 channels suggests
that the S2 transmembrane segment may participate in
channel gating via a charge interaction with the S4 seg-
ment (Papazian et al., 1995; Seoh et al., 1996; Monks et
al., 1999; Milligan and Wray, 2000). Thus, structural
changes in the attached loops may disrupt coordinated
movements of these two transmembrane segments,
thereby altering channel gating properties, including
voltage dependence. Our results indicate that the
highly conserved glycine at position 204 in the S2–S3
loop of the CNG channels may be critical for maintain-
ing a particular structure that is involved in the normal
gating mechanism in wild-type channels.
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